BOSTON — In this Healio Video Perspective from the ASCRS meeting, Abu Abraham, MD, of Cloudbreak Pharma, and John A. Hovanesian, MD, FACS, discuss developments in the treatment of pterygium.
Abraham previews an eye drop solution, currently in a phase 3 clinical trial, designed to treat pterygium through twice-daily dosing.
“The good news for us is that surgeons who are interested in treating pterygium have effective, modern techniques that work very well,” Hovanesian said. “The other good news for both us and patients is that we have medical therapies that (Read more...)